We are live on
!
Find out more
SC
Schulhoff & Co Portfolio holdings
AUM
$243M
1-Year Est. Return
17.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$228M
AUM Growth
+$18.3M
(+8.7%)
Cap. Flow
+$1.9M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
43.77%
Holding
127
New
6
Increased
41
Reduced
33
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$611K |
| 2 |
RTX Corp
RTX
|
+$301K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$249K |
| 4 |
Unum
UNM
|
+$195K |
| 5 |
iShares Silver Trust
SLV
|
+$191K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PGTI
PGT, Inc.
PGTI
|
+$366K |
| 2 |
Eli Lilly
LLY
|
+$142K |
| 3 |
AbbVie
ABBV
|
+$56.9K |
| 4 |
Procter & Gamble
PG
|
+$51K |
| 5 |
Piper Sandler
PIPR
|
+$49.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.24% |
| 2 | Financials | 16.33% |
| 3 | Industrials | 12.22% |
| 4 | Healthcare | 11.57% |
| 5 | Technology | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boeing
BA
$169B
| $255K | 0.11% |
1,320
| – | – |
|
|
HI
102
DELISTED
Hillenbrand
HI
| $251K | 0.11% |
5,000
| – | – |
|
|
FITB
103
Fifth Third Bancorp
FITB
$53.8B
| $251K | 0.11% |
6,753
| – | – |
|
104
Visa
V
$694B
| $251K | 0.11% |
900
| – | – |
|
105
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $248K | 0.11% |
475
| – | – |
|
106
Amgen
AMGN
$201B
| $240K | 0.11% |
844
| – | – |
|
107
Macerich
MAC
$7.32B
| $238K | 0.1% |
13,801
| – | – |
|
108
Diageo
DEO
$47.5B
| $224K | 0.1% |
1,508
| – | – |
|
109
American Electric Power
AEP
$72.4B
| $223K | 0.1% |
2,595
| – | – |
|
|
110
Unum
UNM
$14.3B
| $215K | 0.09% |
+4,000
| New | +$195K |
|
111
FedEx
FDX
$75.9B
| $207K | 0.09% |
+715
| New | +$179K |
|
|
112
iShares Silver Trust
SLV
$27.1B
| $204K | 0.09% |
+8,950
| New | +$191K |
|
113
Kinder Morgan
KMI
$72.4B
| $199K | 0.09% |
10,837
-2,811
| -21% | -$49.1K |
|
|
TGNA
114
DELISTED
TEGNA Inc
TGNA
| $196K | 0.09% |
13,100
| – | – |
|
115
Vanda Pharmaceuticals
VNDA
$328M
| $158K | 0.07% |
+38,500
| New | +$154K |
|
116
Warner Bros
WBD
$68.4B
| $94.6K | 0.04% |
10,838
-1,580
| -13% | -$15.2K |
|
117
Pyxis Oncology
PYXS
$141M
| $93.7K | 0.04% |
22,000
| – | – |
|
118
AmeriServ Financial
ASRV
$66M
| $33.8K | 0.01% |
13,000
| – | – |
|
|
PGTI
119
DELISTED
PGT, Inc.
PGTI
| – | – |
-9,000
| Closed | -$366K |
|
Similar funds
HCM
JAM
SC
YP
HBS
QHA
GIM
BB
Schulhoff & Co's Q1 2024 Portfolio in Review
As of Q1 2024, Schulhoff & Co held 127 positions worth $228M, up 8.7% from $210M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Schulhoff & Co's Q1 2024 filing shows 6 new, 41 increased, 33 reduced and 1 closed positions. Its largest new stake was RTX Corp: 3,336 shares worth $325K. The largest sale was PGT, Inc., an estimated $366K.
By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, down from 28% a quarter earlier, followed by Financials and Industrials.
- Schulhoff & Co's largest Q1 2024 buy was RTX Corp: 3,336 shares worth $325K.
- Schulhoff & Co added most to Avadel Pharmaceuticals in Q1 2024, an estimated $611K increase.
- Schulhoff & Co's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $142K.
- Schulhoff & Co fully exited PGT, Inc. in Q1 2024, selling an estimated $366K.
- Schulhoff & Co's ten largest holdings make up 44% of its $228M portfolio in Q1 2024.
- Schulhoff & Co opened 6 new positions and closed 1 in Q1 2024.
- Schulhoff & Co's portfolio value rose 8.7% quarter-over-quarter to $228M.
Based on Schulhoff & Co's 13F filing for Q1 2024, filed 1 May 2024.